Source: American Journal Respiratory and Critical Care Medicine. Conference titles: International Conference. Unidade: FM
Subjects: DOENÇA PULMONAR (ESPECIALIDADE), ASMA
ABNT
KLUIJVER, J. de et al. Extracellular matrix (ECM) proteoglycans in the airways respond to inhaled steroid treatment despite ongoing allergen exposure in asthma. American Journal Respiratory and Critical Care Medicine. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 out. 2024. , 2003APA
Kluijver, J. de, Schrumpf, J. A., Evertse, C. E., Sont, J. K., Rabe, K. F., Hiemstra, P. S., et al. (2003). Extracellular matrix (ECM) proteoglycans in the airways respond to inhaled steroid treatment despite ongoing allergen exposure in asthma. American Journal Respiratory and Critical Care Medicine. New York: Faculdade de Medicina, Universidade de São Paulo.NLM
Kluijver J de, Schrumpf JA, Evertse CE, Sont JK, Rabe KF, Hiemstra PS, Sterk PJ, Mauad T. Extracellular matrix (ECM) proteoglycans in the airways respond to inhaled steroid treatment despite ongoing allergen exposure in asthma. American Journal Respiratory and Critical Care Medicine. 2003 ; 167( 07): A455.[citado 2024 out. 17 ]Vancouver
Kluijver J de, Schrumpf JA, Evertse CE, Sont JK, Rabe KF, Hiemstra PS, Sterk PJ, Mauad T. Extracellular matrix (ECM) proteoglycans in the airways respond to inhaled steroid treatment despite ongoing allergen exposure in asthma. American Journal Respiratory and Critical Care Medicine. 2003 ; 167( 07): A455.[citado 2024 out. 17 ]